Sales Of Drug-Spiked Supplements After Warnings Show Stronger US Regulation Needed – Study

"FDA should consider ways to ensure that prohibited drugs are removed from supplements, perhaps by testing products sold after warning letters and mandating recalls whenever products remain adulterated,” say Pieter Cohen and colleagues in JAMA study.

• Source: Shutterstock

Nine of 31 dietary supplements identified in US Food and Drug Administration warning letters as containing stimulant drugs remained available for sale an average of six years after the warnings, according to research led by a recognized critic of the agency’s regulation of the industry.

“This study raises questions regarding the FDA’s actions to ensure that manufacturers are compliant with the agency’s warning letters. The...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Compliance

More from Policy & Regulation